Carl Decicco Net Worth & Insider Trades
Carl Decicco - Chief Scientific Officer, Foghorn Therapeutics Inc
What is Carl Decicco's Net Worth?
The current estimated net worth of Foghorn Therapeutics Inc's Chief Scientific Officer, Carl Decicco, is estimated to be about $3.63M . Carl Decicco owns about 258,397 units of Foghorn Therapeutics Inc common stock. In the last year at Foghorn Therapeutics Inc, Carl Decicco has sold an estimated value of $0 worth.
What is Carl Decicco's Past Insider Trading?
Carl Decicco's largest purchase order was 5,500 units , worth over $88K on October 29, 2020. In total, Carl Decicco has made about 3 transactions over a year of their time at Foghorn Therapeutics Inc. Carl Decicco usually trades in February, October and December, with the busiest year in 2021.
CARL DECICCO
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Carl Decicco's Salary in 2020?
As Chief Scientific Officer of Foghorn Therapeutics Inc, Carl Decicco has a total base salary of $412.000 . Carl Decicco received compensation valued at about $1,218,464 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of option awards of $542,224 , other earnings, plans or compensations of $214,240 , and other compensation of $50,000 .
What is Carl Decicco's' Mailing Address?
- Mailing address is 100 Binney Street Suite 610 Cambridge MA 02142 MA
Foghorn Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Adrian Gottschalk | 2020 | $478,950 | - | $1,834,007 | $311,318 | - | $2,624,575 |
| Adrian Gottschalk | 2019 | $465,000 | - | $642,918 | $197,625 | - | $1,305,543 |
| Carl Decicco, Ph.D. | 2020 | $412.000 | - | $542,224 | $214,240 | $50,000 | $1,218,464 |
| Carl Decicco, Ph.D. | 2019 | $400,000 | - | $1,474,337 | $136,000 | $60,000 | $2,070,337 |
| Michael LaCascia | 2020 | $59,423 | $60,000 | $1,869,416 | - | - | $1,988,838 |
| Samuel Agresta, M.D. | 2020 | $412,000 | - | $542,224 | $99,573 | - | $1,053,797 |
| Samuel Agresta, M.D. | 2019 | $116,667 | $300,000 | $785,607 | - | - | $1,202,274 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1822462/000119312521178596/d105885ddef14a.htm
What are Foghorn Therapeutics Inc's Past Insider Trades?
Foghorn Therapeutics Inc's most recent insider trade came on October 29, 2020 by Carl Decicco who bought 5,500 units worth $88K . In the years Foghorn Therapeutics Inc was active, insiders at Foghorn Therapeutics Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Adrian Gottschalk, Chief Executive Officer, Cigall Kadoch, and Allan Reine, Chief Financial Officer .
Foghorn Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||